Abstract:Mayaro virus (MAYV) is a mosquito-borne Alphavirus that is widespread in South America. MAYV infection often presents with non-specific febrile symptoms but may progress to debilitating chronic arthritis or arthralgia. Despite the pandemic threat of MAYV, its true distribution remains unknown. The objective of this study was to clarify the geographic distribution of MAYV using an established risk mapping framework. This consisted of generating evidence consensus scores for MAYV presence, modeling the potential distribution of MAYV in select countries across Central and South America, and estimating the population residing in areas suitable for MAYV transmission. We compiled a georeferenced compendium of MAYV occurrence in humans, animals, and arthropods. Based on an established evidence consensus framework, we integrated multiple information sources to assess the total evidence supporting ongoing transmission of MAYV within each country in our study region. We then developed high resolution maps of the disease's estimated distribution using a boosted regression tree approach. Models were developed using nine climatic and environmental covariates that are related to the MAYV transmission cycle. Using the output of our boosted regression tree models, we estimated the total population living in regions suitable for MAYV transmission. The evidence consensus scores revealed high or very high evidence of MAYV transmission in several countries including Brazil (especially the states of Mato Grosso and Goiás), Venezuela, Peru, Trinidad and Tobago, and French Guiana. According to the boosted regression tree models, a substantial region of South America is suitable for MAYV transmission, including north and central Brazil, French Guiana, and Suriname. Some regions (e.g., Guyana) with only moderate evidence of known transmission were identified as highly suitable for MAYV. We estimate that approximately 58.9 million people (95% CI: 21.4–100.4) in Central and South America live in areas that may be suitable for MAYV transmission, including 46.2 million people (95% CI: 17.6–68.9) in Brazil. Our results may assist in prioritizing high-risk areas for vector control, human disease surveillance and ecological studies. We used a comprehensive, georeferenced compendium of Mayaro virus (MAYV) occurrence to model the suitability for MAYV in Central and South America. Our boosted regression tree model incorporated 195 MAYV occurrence locations and 9 gridded environmental covariates to generate a 5 x 5 km continuous surface of MAYV suitability across Central and South America. Using this distribution model, we estimated the total population residing in areas that are suitable for MAYV transmission. Furthermore, we developed evidence consensus scores for each country in our study region that synthesized a variety of sources to assess the overall evidence of known MAYV transmission. Our study provides a contemporary estimate of MAYV distribution using a well-established disease mapping framework. This information provides an evidence base that can guide disease surveillance (including human cases and ecological studies) and vector control efforts in Central and South America. This is especially useful in regions with high predicted MAYV suitability but only moderate evidence of current MAYV transmission (e.g., Guyana and Suriname).

A cluster of Mayaro virus infections in a film team returning from Suriname, February 2024

Mayaro virus detection in patients from rural and urban areas in Trinidad and Tobago during the Chikungunya and Zika virus outbreaks

Mayaro Virus as the cause of Acute Febrile Illness in the Colombian Amazon Basin

Mayaro Virus: An Emerging Alphavirus in the Americas

Identification of Mayaro Virus Genotype D in Rondônia, Brazil

Case Series of Patients with Marburg Virus Disease, Equatorial Guinea, 2023

Alterations in the Cellular Metabolic Footprint Induced by Mayaro Virus

Unexpected arboviruses found in an epidemiological surveillance of acute tropical febrile syndrome in the department of Meta, Eastern Colombia

Mayaro virus, a potential threat for Europe: vector competence of autochthonous vector species

Understanding transmission risk and predicting environmental suitability for Mayaro Virus in Central and South America

The silent invaders: Oropouche and Melao viruses, causes of increased public health risks for the Americas

Clinical and laboratory diagnosis of Mayaro virus (MAYV): Current status and opportunities for further development

Dengue Virus and Zika Virus Seroprevalence in the South Pacific Populations of the Cook Islands and Vanuatu

Oropouche Virus Disease Among U.S. Travelers - United States, 2024

Current challenges in the discovery of treatments against Mayaro fever

Detection of Dengue Virus 1 and Mammalian Orthoreovirus 3, with Novel Reassortments, in a South African Family Returning from Thailand, 2017

Marburg virus disease: A deadly rare virus is coming.

Oropouche fever cases diagnosed in Italy in two epidemiologically non-related travellers from Cuba, late May to early June 2024

Effects of Chikungunya virus immunity on Mayaro virus disease and epidemic potential

Chikungunya Virus: An Emergent Arbovirus to the South American Continent and a Continuous Threat to the World

Effect of Oral Infection of Mayaro Virus on Fitness Correlates and Expression of Immune Related Genes in Aedes aegypti